Author:
Kozak Zofia,Ciccarone Daniel,Thrul Johannes,Cole Thomas O.,Pappas Alexander L.,Greenblatt Aaron D.,Welsh Christopher,Yoon Mark,Gann Donald,Artigiani E. Erin,Wish Eric D.,Belcher Annabelle M.
Abstract
Abstract
Background
Despite the widespread availability of naloxone, US opioid overdose rates continue to rise. The “Cascade of Care” (CoC) is a public health approach that identifies steps in achieving specific outcomes and has been used to identify gaps in naloxone carriage among individuals with opioid use disorder (OUD). We sought to apply this framework to a treatment-seeking population with OUD that may be more inclined to engage in harm reduction behaviors.
Methods
Patients were recruited from an urban methadone program to complete a survey. We assessed naloxone familiarity, availability, obtainability, training, and possession, as well as naloxone carriage rates, demographics, and harm reduction behaviors. A multivariable logistic regression examined associations between naloxone carriage and individual-level factors.
Results
Participants (n = 97) were majority male (59%), with a mean age of 48 (SD = 12), 27% had college education or higher, 64% indicated injection drug use, and 84% reported past naloxone training. All participants endorsed familiarity with naloxone, but only 42% regularly carried naloxone. The following variables were associated with carrying naloxone: White race (aOR = 2.94, 95% CI 1.02–8.52), college education (aOR = 8.11, 95% CI 1.76–37.47), and total number of self-reported harm reduction behaviors (aOR = 1.45, 95% CI 1.00–2.11).
Conclusion
We found low rates of naloxone carriage among methadone-treated patients. Methadone programs provide opportunities for naloxone interventions and should target racial/ethnic minorities and individuals with lower education. The spectrum of harm reduction behaviors should be encouraged among these populations to enhance naloxone carriage.
Funder
National Institute on Drug Abuse
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Medicine (miscellaneous)
Reference20 articles.
1. Ahmad FB, Rossen LM, Sutton P. Provisional drug overdose data. National Center for Health Statistics [Internet]. 2021 [cited 2022 Apr 26]. http://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm.
2. SAMHSA. SAMHSA directing $932 million to nation’s communities through the continuation of its State Opioid Response grant funding [Internet]. 2019 [cited 2022 Apr 28]. https://www.samhsa.gov/newsroom/press-announcements/201909041245.
3. Coffin P, Sullivan S. Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal | Annals of Internal Medicine [Internet]. 2013 [cited 2022 May 16]. https://doi.org/10.7326/0003-4819-158-1-201301010-00003.
4. Buresh M, Gicquelais RE, Astemborski J, Kirk GD, Mehta SH, Genberg BL. Fatal overdose prevention and experience with naloxone: a cross-sectional study from a community-based cohort of people who inject drugs in Baltimore, Maryland. PLoS ONE. 2020;15(3):e0230127.
5. Burton G, McAuley A, Schofield J, Yeung A, Matheson C, Parkes T. A systematic review and meta-analysis of the prevalence of take-home naloxone (THN) ownership and carriage. Int J Drug Policy. 2021;1(96):103298.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献